YKL-06-061

N/A

Report date: 2023/11/14 11:35:12
NME

Base Information

Drug NameYKL-06-061
Drug Alias NameYKL-06-061
ClassificationOther
Mechanisms of ActionSalt-inducible kinases inhibitors
TargetsSalt-inducible kinases
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity of South China
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A